Diabetes Injection Pen Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Type (Disposable Injection Pens, Reusable Injection Pens); By Therapy (Diabetes, Growth Hormone Therapy, Fertility, Osteoporosis, Other Therapies); By End User (Home care, Hospital and Clinics) and Geography
Report Code: TIPRE00004552
| No. of Pages: 150
| Category: Medical Device
| Status: Upcoming
Diabetes is a disease that affect how your body uses blood sugar (glucose). Glucose is important source of energy for the cell that make up your muscles and tissue. Diabetes Injection Pen are medical device which are used to treatment of diabetes. Managing diabetes often required taking insulin shots throughout the day. The diabetes injection pen is used to inject insulin with high accuracy dose form in the body. The diabetes injection pen is known for easier to use and higher dose accuracy.
MARKET DYNAMICS
The diabetes injection pen market is expected to grow during the forecast period due to the changing life style and consumption of unhealthy food, increasing prevalence of diabetes, daily need of consumption of insulin dose. The rising predominance of diabetes in different age category is encourage the growth of diabetes injection pen market. Raising awareness of diabetes treatment will increase diabetes injection pen market. Growing R&D activities is likely to show positive impact on market growth.
MARKET SCOPE
The "Globally Diabetes Injection Pen Market Analysis to 2028" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of diabetes injection pen with detailed market segmentation by product type, therapy, end user and geography. The globally diabetes injection pen market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading diabetes injection pen market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global diabetes injection pen market is segmented on the basis of product type, therapy and end user. Based on products type, the market is segmented as disposable injection pen and reusable injection pen. On the basis of therapy, the global diabetes injection pen market is segmented into diabetes growth hormone therapy, fertility, osteoporosis and other therapies. Based on end user, the market segmented into homecare, hospital and clinics.
Get more information on this report :
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global diabetes injection pen market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America The diabetes injection pen market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Asthma therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the global diabetes injection pen market in these regions.
Get more information on this report :
MARKET PLAYERS
The reports cover key developments in the global diabetes injection pen market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from the diabetes injection pen market are anticipated to lucrative growth opportunities in the future with the rising demand for diabetes injection pen market in the global market. Below mentioned is the list of few companies engaged in the global diabetes injection pen market.
The report also includes the profiles of key the global diabetes injection pen market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Novo Nordisk
Eli Lilly and company
Sanofi
Merck & Co., Inc.
Ypsomed AG
F. Hoffman-La Roche Ltd.
BD
Pfizer Inc.
Haselmeier
Owen Mumford
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advance statistical expertise and offer various customization options in the existing study.
Get more information on this report :
TABLE OF CONTENTS
1. INTRODUCTION 1.1. SCOPE OF THE STUDY 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 1.3. MARKET SEGMENTATION 1.3.1 Diabetes Injection Pens Market - By Type 1.3.2 Diabetes Injection Pens Market - By Therapy 1.3.3 Diabetes Injection Pens Market - By End User 1.3.4 Diabetes Injection Pens Market - By Region 1.3.4.1 by Country 2. KEY TAKEWAYS 3. RESEARCH METHODOLOGY 4. DIABETES INJECTION PENS MARKET LANDSCAPE 4.1. OVERVIEW 4.2. PEST ANALYSIS 4.2.1 North America - Pest Analysis 4.2.2 Europe - Pest Analysis 4.2.3 Asia-Pacific - Pest Analysis 4.2.4 Middle East and Africa - Pest Analysis 4.2.5 South and Central America - Pest Analysis 4.3. EXPERT OPINIONS 5. DIABETES INJECTION PENS MARKET - KEY MARKET DYNAMICS 5.1. KEY MARKET DRIVERS 5.2. KEY MARKET RESTRAINTS 5.3. KEY MARKET OPPORTUNITIES 5.4. FUTURE TRENDS 5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC 6. DIABETES INJECTION PENS MARKET - GLOBAL MARKET ANALYSIS 6.1. DIABETES INJECTION PENS - GLOBAL MARKET OVERVIEW 6.2. DIABETES INJECTION PENS - GLOBAL MARKET AND FORECAST TO 2028 6.3. MARKET POSITIONING/MARKET SHARE 7. DIABETES INJECTION PENS MARKET - REVENUE AND FORECASTS TO 2028 -TYPE 7.1. OVERVIEW 7.2. BY TYPE MARKET FORECASTS AND ANALYSIS 7.3. DISPOSABLE INJECTION PENS 7.3.1. Overview 7.3.2. Disposable injection pens Market Forecast and Analysis 7.4. REUSABLE INJECTION PENS 7.4.1. Overview 7.4.2. Reusable injection pens Market Forecast and Analysis 8. DIABETES INJECTION PENS MARKET - REVENUE AND FORECASTS TO 2028 -THERAPY 8.1. OVERVIEW 8.2. BY THERAPY MARKET FORECASTS AND ANALYSIS 8.3. DIABETES 8.3.1. Overview 8.3.2. Diabetes Market Forecast and Analysis 8.3.3. Insulin Market 8.3.3.1. Overview 8.3.3.2. Insulin Market Forecast and Analysis 8.3.4. GLP-1 Market 8.3.4.1. Overview 8.3.4.2. GLP-1 Market Forecast and Analysis 8.4. GROWTH HORMONE THERAPY 8.4.1. Overview 8.4.2. Growth hormone therapy Market Forecast and Analysis 8.5. FERTILITY 8.5.1. Overview 8.5.2. Fertility Market Forecast and Analysis 8.6. OSTEOPOROSIS 8.6.1. Overview 8.6.2. Osteoporosis Market Forecast and Analysis 8.7. OTHER THERAPIES 8.7.1. Overview 8.7.2. Other Therapies Market Forecast and Analysis 9. DIABETES INJECTION PENS MARKET - REVENUE AND FORECASTS TO 2028 -END USER 9.1. OVERVIEW 9.2. BY END USER MARKET FORECASTS AND ANALYSIS 9.3. HOME CARE 9.3.1. Overview 9.3.2. Home care Market Forecast and Analysis 9.4. HOSPITAL AND CLINICS 9.4.1. Overview 9.4.2. Hospital and clinics Market Forecast and Analysis 10. DIABETES INJECTION PENS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS 10.1. NORTH AMERICA 10.1.1 North America Diabetes Injection Pens Market Overview 10.1.2 North America Diabetes Injection Pens Market Forecasts and Analysis 10.1.3 North America Diabetes Injection Pens Market Forecasts and Analysis - By Type 10.1.4 North America Diabetes Injection Pens Market Forecasts and Analysis - By Therapy 10.1.5 North America Diabetes Injection Pens Market Forecasts and Analysis - By End User 10.1.6 North America Diabetes Injection Pens Market Forecasts and Analysis - By Countries 10.1.6.1 United States Diabetes Injection Pens Market 10.1.6.1.1 United States Diabetes Injection Pens Market by Type 10.1.6.1.2 United States Diabetes Injection Pens Market by Therapy 10.1.6.1.3 United States Diabetes Injection Pens Market by End User 10.1.6.2 Canada Diabetes Injection Pens Market 10.1.6.2.1 Canada Diabetes Injection Pens Market by Type 10.1.6.2.2 Canada Diabetes Injection Pens Market by Therapy 10.1.6.2.3 Canada Diabetes Injection Pens Market by End User 10.1.6.3 Mexico Diabetes Injection Pens Market 10.1.6.3.1 Mexico Diabetes Injection Pens Market by Type 10.1.6.3.2 Mexico Diabetes Injection Pens Market by Therapy 10.1.6.3.3 Mexico Diabetes Injection Pens Market by End User 10.2. EUROPE 10.2.1 Europe Diabetes Injection Pens Market Overview 10.2.2 Europe Diabetes Injection Pens Market Forecasts and Analysis 10.2.3 Europe Diabetes Injection Pens Market Forecasts and Analysis - By Type 10.2.4 Europe Diabetes Injection Pens Market Forecasts and Analysis - By Therapy 10.2.5 Europe Diabetes Injection Pens Market Forecasts and Analysis - By End User 10.2.6 Europe Diabetes Injection Pens Market Forecasts and Analysis - By Countries 10.2.6.1 Germany Diabetes Injection Pens Market 10.2.6.1.1 Germany Diabetes Injection Pens Market by Type 10.2.6.1.2 Germany Diabetes Injection Pens Market by Therapy 10.2.6.1.3 Germany Diabetes Injection Pens Market by End User 10.2.6.2 France Diabetes Injection Pens Market 10.2.6.2.1 France Diabetes Injection Pens Market by Type 10.2.6.2.2 France Diabetes Injection Pens Market by Therapy 10.2.6.2.3 France Diabetes Injection Pens Market by End User 10.2.6.3 Italy Diabetes Injection Pens Market 10.2.6.3.1 Italy Diabetes Injection Pens Market by Type 10.2.6.3.2 Italy Diabetes Injection Pens Market by Therapy 10.2.6.3.3 Italy Diabetes Injection Pens Market by End User 10.2.6.4 Spain Diabetes Injection Pens Market 10.2.6.4.1 Spain Diabetes Injection Pens Market by Type 10.2.6.4.2 Spain Diabetes Injection Pens Market by Therapy 10.2.6.4.3 Spain Diabetes Injection Pens Market by End User 10.2.6.5 United Kingdom Diabetes Injection Pens Market 10.2.6.5.1 United Kingdom Diabetes Injection Pens Market by Type 10.2.6.5.2 United Kingdom Diabetes Injection Pens Market by Therapy 10.2.6.5.3 United Kingdom Diabetes Injection Pens Market by End User 10.2.6.6 Rest of Europe Diabetes Injection Pens Market 10.2.6.6.1 Rest of Europe Diabetes Injection Pens Market by Type 10.2.6.6.2 Rest of Europe Diabetes Injection Pens Market by Therapy 10.2.6.6.3 Rest of Europe Diabetes Injection Pens Market by End User 10.3. ASIA-PACIFIC 10.3.1 Asia-Pacific Diabetes Injection Pens Market Overview 10.3.2 Asia-Pacific Diabetes Injection Pens Market Forecasts and Analysis 10.3.3 Asia-Pacific Diabetes Injection Pens Market Forecasts and Analysis - By Type 10.3.4 Asia-Pacific Diabetes Injection Pens Market Forecasts and Analysis - By Therapy 10.3.5 Asia-Pacific Diabetes Injection Pens Market Forecasts and Analysis - By End User 10.3.6 Asia-Pacific Diabetes Injection Pens Market Forecasts and Analysis - By Countries 10.3.6.1 Australia Diabetes Injection Pens Market 10.3.6.1.1 Australia Diabetes Injection Pens Market by Type 10.3.6.1.2 Australia Diabetes Injection Pens Market by Therapy 10.3.6.1.3 Australia Diabetes Injection Pens Market by End User 10.3.6.2 China Diabetes Injection Pens Market 10.3.6.2.1 China Diabetes Injection Pens Market by Type 10.3.6.2.2 China Diabetes Injection Pens Market by Therapy 10.3.6.2.3 China Diabetes Injection Pens Market by End User 10.3.6.3 India Diabetes Injection Pens Market 10.3.6.3.1 India Diabetes Injection Pens Market by Type 10.3.6.3.2 India Diabetes Injection Pens Market by Therapy 10.3.6.3.3 India Diabetes Injection Pens Market by End User 10.3.6.4 Japan Diabetes Injection Pens Market 10.3.6.4.1 Japan Diabetes Injection Pens Market by Type 10.3.6.4.2 Japan Diabetes Injection Pens Market by Therapy 10.3.6.4.3 Japan Diabetes Injection Pens Market by End User 10.3.6.5 South Korea Diabetes Injection Pens Market 10.3.6.5.1 South Korea Diabetes Injection Pens Market by Type 10.3.6.5.2 South Korea Diabetes Injection Pens Market by Therapy 10.3.6.5.3 South Korea Diabetes Injection Pens Market by End User 10.3.6.6 Rest of Asia-Pacific Diabetes Injection Pens Market 10.3.6.6.1 Rest of Asia-Pacific Diabetes Injection Pens Market by Type 10.3.6.6.2 Rest of Asia-Pacific Diabetes Injection Pens Market by Therapy 10.3.6.6.3 Rest of Asia-Pacific Diabetes Injection Pens Market by End User 10.4. MIDDLE EAST AND AFRICA 10.4.1 Middle East and Africa Diabetes Injection Pens Market Overview 10.4.2 Middle East and Africa Diabetes Injection Pens Market Forecasts and Analysis 10.4.3 Middle East and Africa Diabetes Injection Pens Market Forecasts and Analysis - By Type 10.4.4 Middle East and Africa Diabetes Injection Pens Market Forecasts and Analysis - By Therapy 10.4.5 Middle East and Africa Diabetes Injection Pens Market Forecasts and Analysis - By End User 10.4.6 Middle East and Africa Diabetes Injection Pens Market Forecasts and Analysis - By Countries 10.4.6.1 South Africa Diabetes Injection Pens Market 10.4.6.1.1 South Africa Diabetes Injection Pens Market by Type 10.4.6.1.2 South Africa Diabetes Injection Pens Market by Therapy 10.4.6.1.3 South Africa Diabetes Injection Pens Market by End User 10.4.6.2 Saudi Arabia Diabetes Injection Pens Market 10.4.6.2.1 Saudi Arabia Diabetes Injection Pens Market by Type 10.4.6.2.2 Saudi Arabia Diabetes Injection Pens Market by Therapy 10.4.6.2.3 Saudi Arabia Diabetes Injection Pens Market by End User 10.4.6.3 U.A.E Diabetes Injection Pens Market 10.4.6.3.1 U.A.E Diabetes Injection Pens Market by Type 10.4.6.3.2 U.A.E Diabetes Injection Pens Market by Therapy 10.4.6.3.3 U.A.E Diabetes Injection Pens Market by End User 10.4.6.4 Rest of Middle East and Africa Diabetes Injection Pens Market 10.4.6.4.1 Rest of Middle East and Africa Diabetes Injection Pens Market by Type 10.4.6.4.2 Rest of Middle East and Africa Diabetes Injection Pens Market by Therapy 10.4.6.4.3 Rest of Middle East and Africa Diabetes Injection Pens Market by End User 10.5. SOUTH AND CENTRAL AMERICA 10.5.1 South and Central America Diabetes Injection Pens Market Overview 10.5.2 South and Central America Diabetes Injection Pens Market Forecasts and Analysis 10.5.3 South and Central America Diabetes Injection Pens Market Forecasts and Analysis - By Type 10.5.4 South and Central America Diabetes Injection Pens Market Forecasts and Analysis - By Therapy 10.5.5 South and Central America Diabetes Injection Pens Market Forecasts and Analysis - By End User 10.5.6 South and Central America Diabetes Injection Pens Market Forecasts and Analysis - By Countries 10.5.6.1 Brazil Diabetes Injection Pens Market 10.5.6.1.1 Brazil Diabetes Injection Pens Market by Type 10.5.6.1.2 Brazil Diabetes Injection Pens Market by Therapy 10.5.6.1.3 Brazil Diabetes Injection Pens Market by End User 10.5.6.2 Argentina Diabetes Injection Pens Market 10.5.6.2.1 Argentina Diabetes Injection Pens Market by Type 10.5.6.2.2 Argentina Diabetes Injection Pens Market by Therapy 10.5.6.2.3 Argentina Diabetes Injection Pens Market by End User 10.5.6.3 Rest of South and Central America Diabetes Injection Pens Market 10.5.6.3.1 Rest of South and Central America Diabetes Injection Pens Market by Type 10.5.6.3.2 Rest of South and Central America Diabetes Injection Pens Market by Therapy 10.5.6.3.3 Rest of South and Central America Diabetes Injection Pens Market by End User 11. INDUSTRY LANDSCAPE 11.1. MERGERS AND ACQUISITIONS 11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES 11.3. NEW PRODUCT LAUNCHES 11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS 12. DIABETES INJECTION PENS MARKET, KEY COMPANY PROFILES 12.1. NOVO NORDISK 12.1.1. Key Facts 12.1.2. Business Description 12.1.3. Products and Services 12.1.4. Financial Overview 12.1.5. SWOT Analysis 12.1.6. Key Developments 12.2. ELI LILLY AND COMPANY 12.2.1. Key Facts 12.2.2. Business Description 12.2.3. Products and Services 12.2.4. Financial Overview 12.2.5. SWOT Analysis 12.2.6. Key Developments 12.3. SANOFI 12.3.1. Key Facts 12.3.2. Business Description 12.3.3. Products and Services 12.3.4. Financial Overview 12.3.5. SWOT Analysis 12.3.6. Key Developments 12.4. MERCK & CO., INC 12.4.1. Key Facts 12.4.2. Business Description 12.4.3. Products and Services 12.4.4. Financial Overview 12.4.5. SWOT Analysis 12.4.6. Key Developments 12.5. YPSOMED AG 12.5.1. Key Facts 12.5.2. Business Description 12.5.3. Products and Services 12.5.4. Financial Overview 12.5.5. SWOT Analysis 12.5.6. Key Developments 12.6. ASTRAZENECA 12.6.1. Key Facts 12.6.2. Business Description 12.6.3. Products and Services 12.6.4. Financial Overview 12.6.5. SWOT Analysis 12.6.6. Key Developments 12.7. F.HOFFMAN-LA ROCHE LTD. 12.7.1. Key Facts 12.7.2. Business Description 12.7.3. Products and Services 12.7.4. Financial Overview 12.7.5. SWOT Analysis 12.7.6. Key Developments 12.8. BD 12.8.1. Key Facts 12.8.2. Business Description 12.8.3. Products and Services 12.8.4. Financial Overview 12.8.5. SWOT Analysis 12.8.6. Key Developments 12.9. PFIZER, INC. 12.9.1. Key Facts 12.9.2. Business Description 12.9.3. Products and Services 12.9.4. Financial Overview 12.9.5. SWOT Analysis 12.9.6. Key Developments 12.10. HASELMEIER 12.10.1. Key Facts 12.10.2. Business Description 12.10.3. Products and Services 12.10.4. Financial Overview 12.10.5. SWOT Analysis 12.10.6. Key Developments 12.11. OWEN MUMFORD 12.11.1. Key Facts 12.11.2. Business Description 12.11.3. Products and Services 12.11.4. Financial Overview 12.11.5. SWOT Analysis 12.11.6. Key Developments
13. APPENDIX 13.1. ABOUT THE INSIGHT PARTNERS 13.2. GLOSSARY OF TERMS
The List of Companies
1. Novo Nordisk 2. Eli lilly and company 3. Sanofi 4. Merck & Co., Inc. 5. Ypsomed AG 6. F. Hoffman-La Roche Ltd. 7. BD 8. Pfizer Inc. 9. Haselmeier 10. Owen Mumford
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.